HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
<h4>Background</h4>The relationship between statin treatment and Coronavirus Disease 2019 (COVID-19) mortality has been discussed due to the pleiotropic effects of statins on coagulation and immune mechanisms. However, available observational studies are hampered by study design flaws, r...
Guardado en:
Autores principales: | Rita Bergqvist, Viktor H Ahlqvist, Michael Lundberg, Maria-Pia Hergens, Johan Sundström, Max Bell, Cecilia Magnusson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd98dca249f247aab361517904b82231 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.
por: Richard D Moore, et al.
Publicado: (2011) -
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
por: Shi-You Jiang, et al.
Publicado: (2018) -
Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
por: Rania Elsabrouty, et al.
Publicado: (2021) -
Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
por: Minky Son, et al.
Publicado: (2013) -
<i>Aster glehni</i> F. Schmidt Extract Modulates the Activities of HMG-CoA Reductase and Fatty Acid Synthase
por: Hyunbeom Lee, et al.
Publicado: (2021)